Navigation Links
MAP Pharmaceuticals to Present at the 2008 Citi Investment Research Global Healthcare Conference
Date:5/16/2008

MOUNTAIN VIEW, Calif., May 16 /PRNewswire-FirstCall/ -- MAP Pharmaceuticals, Inc. (Nasdaq: MAPP) today announced that the Company will present at the 2008 Citi Investment Research Global Healthcare Conference on Wednesday, May 21, 2008, at 9:00 am (ET) in New York City.

A live webcast of the presentation will be available on the Investor Relations section of MAP Pharmaceuticals' website at http://www.mappharma.com. A replay will also be available within 24 hours for seven days following the presentation.

About MAP Pharmaceuticals, Inc.

MAP Pharmaceuticals develops and plans to commercialize new therapies for children and adults who suffer from chronic conditions that it believes are not adequately treated by currently available medicines. The Company applies its proprietary inhalation technologies to enhance the therapeutic benefits and commercial attractiveness of proven drugs while minimizing risk by capitalizing on their known safety, efficacy and commercialization history. MAP Pharmaceuticals has two drug candidates, Unit Dose Budesonide and MAP0004, in late stage development for the potential treatment of pediatric asthma and migraine respectively. MAP Pharmaceuticals' pipeline also includes a drug candidate in early clinical development for the treatment of asthma and chronic obstructive pulmonary disease.

Additional information about MAP Pharmaceuticals can be found at http://www.mappharma.com.


'/>"/>
SOURCE MAP Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Indevus Pharmaceuticals Scheduled to Present at Upcoming Investor Conferences
2. Transdel Pharmaceuticals Closes $4 Million Financing
3. XTL Biopharmaceuticals to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
4. Sagent Pharmaceuticals Provides US$20,000 in Aid to Earthquake-Devastated Areas in Central China
5. Access Pharmaceuticals to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
6. Memory Pharmaceuticals Reports First Quarter 2008 Financial Results
7. Jazz Pharmaceuticals, Inc. Announces First Quarter 2008 Financial Results
8. Peregrine Pharmaceuticals Reports Studies Published in Science Highlight Key Role of Phosphatidylserine (PS) in Viral Infections
9. Medimetriks Pharmaceuticals, Inc. Begins Operations
10. SGX Pharmaceuticals Announces First Quarter Financial Results and Gives Pipeline Update
11. ADVENTRX Pharmaceuticals to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)...ring industry-leading event September 10 - 11, ...URN HILLS, Mich., Sept. 5 /- Plexus S...software for the medical manufacturing,enterprise,...gy Conference,September 10-11, 2008 at the San Jos..., (Logo: http://www.newscom.com/cgi-bin/prnh/200...
(Date:9/5/2008)...ember 5 /- The 33rd ESMO Congress,in ...gy, serves as a,meeting place for medical oncologi...th colleagues from other disciplines., The Congre...interaction, a teaching ground, and a place to dis... cancer research in Europe, the training of young,...
(Date:9/5/2008)...- BioSpecifics,Technologies...ical company,developing first in class collagenase...d an agreement to significantly improve the deal t... Peyronie,s disease by buying down its,future roya...oSpecifics has modified its previously announced a...
(Date:9/4/2008)... 4 /- MedQuist Inc.,(Nasdaq...ors has elected John,F. Jastrem, Colin J. O,Brien,...tember 4, 2008. Prior to the election of the new d... of the board from seven to 10 members., Accordin...a, "We are,pleased to have this opportunity to fur...
Breaking Biology Technology:Plexus Systems, Inc. to Exhibit at BIOMEDevice Medical Technology Conference 233rd ESMO Congress in Stockholm, 12-16 September 2008 233rd ESMO Congress in Stockholm, 12-16 September 2008 333rd ESMO Congress in Stockholm, 12-16 September 2008 433rd ESMO Congress in Stockholm, 12-16 September 2008 5BioSpecifics Technologies Corp. Buys Down Royalties for Peyronie's Disease 2MedQuist Announces Additions to Board of Directors 2MedQuist Announces Additions to Board of Directors 3
...Scanner 3000 , New Advances in Scanner Desi...mic Range , , , The Af...oundation for continued evolution of the GeneChip ...m, supporting continued feature size reduction for... of microarray-based products. The Affymetrix Gene...
...s Damaskinos a , Arthur E. Dixon a and Lucy E. J...., A12-550 Parkside Dr., Waterloo, Ontario N2L 5V4,...d Laurier University, 75 University Ave. W., Water... ABSTRACT , Conventional widefield light...been indispensable for pathology and drug discover...
...d Mass Spectrometry Application Report , K...Deca XP Plus Equine serum Acepromazine , ...n Jose, CA USA , Wayne Skinner and S... Introduction , Acepromazine is w... tranquilizer to better facilitate handling of the...
...d Mass Spectrometry Application Note , Key...antum Discovery Enhanced Mass- Resolution , ...ry Tucker 1 , and Walter Korfmacher 1 , ...inetics, Schering-Plough Research Institute, Kenil...omerset, NJ, USA , Overview , ...
Other Biology Technology:The Affymetrix GeneChip Scanner 3000, New Advances in Scanner Design for Superior Performance, Reliability, and Dynamic Range 2The Affymetrix GeneChip Scanner 3000, New Advances in Scanner Design for Superior Performance, Reliability, and Dynamic Range 3The Affymetrix GeneChip Scanner 3000, New Advances in Scanner Design for Superior Performance, Reliability, and Dynamic Range 4The Affymetrix GeneChip Scanner 3000, New Advances in Scanner Design for Superior Performance, Reliability, and Dynamic Range 5The Affymetrix GeneChip Scanner 3000, New Advances in Scanner Design for Superior Performance, Reliability, and Dynamic Range 6The Affymetrix GeneChip Scanner 3000, New Advances in Scanner Design for Superior Performance, Reliability, and Dynamic Range 7The Affymetrix GeneChip Scanner 3000, New Advances in Scanner Design for Superior Performance, Reliability, and Dynamic Range 8The Affymetrix GeneChip Scanner 3000, New Advances in Scanner Design for Superior Performance, Reliability, and Dynamic Range 9The Affymetrix GeneChip Scanner 3000, New Advances in Scanner Design for Superior Performance, Reliability, and Dynamic Range 10A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 2A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 3A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 4A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 5A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 6A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 7A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 8A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 9A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 10A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 11A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 12A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 13A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 14A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 15A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 16A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 17A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 18A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 19A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 20A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 21A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 22A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 23A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 24A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 25A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 26A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 27
(Date:9/5/2008)...ulations of wild animals face the challenge of sur...ial College London and Universit Claude Bernard Ly...sland off the west coast of Scotland responds to t...ailability and the unpredictability of winter stor...vealed, "When times are good and food is plentiful...
(Date:9/5/2008)...cksburg, Va. -- Innovative work on a new type of h...ssistant professor of mechanical engineering at Vi... Early Career Development (CAREER) award of $400,0... development of specific models and experiments to...with a stent that has a unique type of in situ pol...
(Date:9/5/2008)...ess release is available in French and Spanish ...ment of Nutrition and Bromatology and Department...da have carried out a study in which they have re...e university population who follows Ramadan. , A...time macronutrient consumption levels are not appr...
(Date:9/4/2008)...g, 5 September 2008 Even scientists define ,a gen...se that the media also have various ways of framin...appearing in the October 2008 issue of EMBO repor...e analysis of 300 articles in British and Norwegia...Mail from the UK; and Aftenposten, Dagbladet, and ...
Breaking Biology News(10 mins):Goulbourne earns NSF award to research heart stent sensors 2Goulbourne earns NSF award to research heart stent sensors 3Nutritionists of the UGR suggest diet improvements during Ramadan 2What is a gene? 2More Than 78 000 are Dead and Millions are Homeless After Cyclone Nargis Swept Through Myanmar 20722 1More Than 78 000 are Dead and Millions are Homeless After Cyclone Nargis Swept Through Myanmar 20722 2PROMACTA 28R 29 28eltrombopag 29 RECEIVES UNANIMOUS RECOMMENDATION BY FDA ADVISORY PANEL 20720 1PROMACTA 28R 29 28eltrombopag 29 RECEIVES UNANIMOUS RECOMMENDATION BY FDA ADVISORY PANEL 20720 2PROMACTA 28R 29 28eltrombopag 29 RECEIVES UNANIMOUS RECOMMENDATION BY FDA ADVISORY PANEL 20720 3PROMACTA 28R 29 28eltrombopag 29 RECEIVES UNANIMOUS RECOMMENDATION BY FDA ADVISORY PANEL 20720 4MDwise Enrollment Exceeds 300 000 Members 20718 1MDwise Enrollment Exceeds 300 000 Members 20718 2EPA Approves XDS CALUX 28R 29 as Alternate Dioxin Test Method 4435 2245 1EPA Approves XDS CALUX 28R 29 as Alternate Dioxin Test Method 4435 2245 2
...ive project with implications,for malaria vaccine ...mics and gene expression studies to trace how mala...move between their hosts and insect,vectors.,That ...ing researchers,understand when different genes sw...ugh seven different life stages. In turn, that,mol...
...nal team of scientists has used gene therapy in tw...e normal movements in monkeys and rats with a drug...rch, detailed online in the scientific publication...ly describes one strategy to halt Parkinson,s dise... devastating side effects that occur when treating...
...Library of Medicine, a part of the National Instit...election from the papers of one of the twentieth c...s Profiles in Science Web site. , ,Don,t miss Cri...test collection on Profiles in Science represents ... of Medicine and the Wellcome Library for the Hist...
...rted last week reveal how an,evolutionary innovati...species has given rise to a deep-seated dependency...ulations.,The new work illustrates how genetic exc...n give rise to a system of interdependence at a,hi..., the production of,worker ants for both species. ...
Other Biology News:Scientists reveal molecular secrets of the malaria parasite 2Scientists reveal molecular secrets of the malaria parasite 3Gene Therapy For Parkinson's Disease Moves Forward In Animals 2Gene Therapy For Parkinson's Disease Moves Forward In Animals 3Gene Therapy For Parkinson's Disease Moves Forward In Animals 4Papers of DNA Pioneer and Nobel Laureate Francis Crick Added to National Library of Medicine’s Profiles in Science Web Site 2Papers of DNA Pioneer and Nobel Laureate Francis Crick Added to National Library of Medicine’s Profiles in Science Web Site 3Ants Genetic Engineering Leads To Species Interdependency 2
This buffer is Specifically formulated to be used with Endogen's Poly-HRP Streptavidin
...ice-coil scanning and positioning system is design... positioned or scanned with high velocity and high...ompared to micropositioners with conventional lead...iven by an integrated, non-contact, zero-friction,...
... Synthesis and Labeling Kit generates labeled cDNA...First unmodified cDNA is made via a reverse transc...mer. Unlike other methods, there are no unnatural ...tion reaction. This unmodified cDNA is then labele...
...roducts feature a dual strength adhesive system wh...er use. The adhesives on either side of the frame ... to the glass has an easy release adhesive whereas... a stronger bond. This means that when the coversl...
Biology Products: